GSK’s U.S. Sales Reps “Europeanized”: No Longer Rewarded for Ability to Push Prescriptions
An anonymous poster to CafePharma described what the
Pharma Spending on Internet, DTC, and Docs
How much money the pharmaceutical industry spends on Internet marketing, direct-to-consumer advertising, and physician detailing are always topics of interest and 2010 was no exception. 2010 was, however, a turning point in bringing more attention to payments made to physicians for speaking, consulting, and research.
PR & Interactive Agencies Vie for Pharma Social Media Campaign Crumbs
Should a PR firm or an interactive marketing agency be in charge of pharma social media campaigns?
Deconstructing Pitts’ Guiding Principles for Pharma Social Media
Peter Pitts, author of DrugWonks Blog, has put together 11
Pharma Marketing News Vol. 10, No. 15: 12 October 2011
Welcome to Volume 10, Issue #15 (12 OCTOBER 2011) of Pharma Marketing News.
The Pozen Digital Advisory Board
A conversation with Elizabeth A. Cermak, EVP, and Chief Commercial Officerat Pozen, Raj Amin, CEO and Co-Founder of HealthiNation, and Bonin Bough, Senior Global Director of Digital and Social Media, PepsiCo, about the who, what, why behind the Pozen Digital Advisory Board, an esteemed group of digital thought-leaders both in and outside of healthcare.
Pfizer Battles to Protect Lipitor Cash Cow
Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand.
Pharma Marketing News Vol. 10, No. 11: 21 June 2011
Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.
Good Promotion Practices Alliance
Plenty of attention being paid to pharmaceutical marketing fraud and abuse cases in blogs and in the general media. But there hasn't been much attention paid to good compliance solutions or best practices. That's the mission of the Good Promotion Practices Alliance (GPP), which is co-sponsored by Reprints Desk and Prolifiq Software.
Limiting Bias in Commercially Supported CME
Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article.
